Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory, Nigeria. This program demonstrated significant improvements in hypertension treatment and control. HTN 2.0 will expand implementation of the HEARTS bundle to 5 new states in 5 geopolitical zones in Nigeria (Abia, Delta, Gombe, Jigawa, and Oyo) while also evaluating sustainment of hypertension control in the Federal Capital Territory.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
This program will not include any of the following special populations:
Primary purpose
Allocation
Interventional model
Masking
10,000 participants in 1 patient group
Loading...
Central trial contact
Mark Huffman, MD; Dike Ojji, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal